Difference between revisions of "CNS5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(17 intermediate revisions by 2 users not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 +
__TOC__
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
 
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
Line 17: Line 18:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
+
|
 +
====CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)====
 
|
 
|
 
----
 
----
Line 68: Line 70:
 
|LS
 
|LS
 
|
 
|
−
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
+
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
 
|-
 
|-
 
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
Line 75: Line 77:
 
|6/27/2023
 
|6/27/2023
 
|
 
|
−
|PENDING
+
|COMPLETE
 
|
 
|
 
|LS
 
|LS
Line 105: Line 107:
 
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
 
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
 
|Disease
 
|Disease
 +
|Scott Smith
 +
|5/3/2024
 
|
 
|
 +
|PENDING
 
|
 
|
−
|
+
|LS
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 135: Line 137:
 
|
 
|
 
|2021 template added
 
|2021 template added
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
Line 156: Line 169:
 
|
 
|
 
|
 
|
−
|2021 template added
+
|
 
|-
 
|-
 
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
 
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
Line 245: Line 258:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
Line 314: Line 338:
 
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 
|Disease
 
|Disease
 +
|Laveniya Satgunaseelan
 +
|9/11/2024
 
|
 
|
 +
|Pending
 
|
 
|
 
|
 
|
 
|
 
|
−
|
+
|Testing 9/2024 somatic template
−
|
+
|-
−
|
+
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
−
|
+
|Disease
−
|-
 
−
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 355: Line 379:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
Line 465: Line 500:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
Line 488: Line 534:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 3 (CHOROID PLEXUS TUMOURS)
+
|
 +
====CHAPTER 3 (CHOROID PLEXUS TUMOURS)====
 
|
 
|
 
----
 
----
Line 541: Line 588:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 4 (EMBRYONAL TUMOURS)
+
|
 +
====CHAPTER 4 (EMBRYONAL TUMOURS)====
 
|
 
|
 
----
 
----
Line 593: Line 641:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
Line 682: Line 741:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 5 (PINEAL TUMOURS)
+
|
 +
====CHAPTER 5 (PINEAL TUMOURS)====
 
|
 
|
 
----
 
----
Line 712: Line 772:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
Line 757: Line 828:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
+
|
 +
====CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)====
 
|
 
|
 
----
 
----
Line 831: Line 903:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
Line 854: Line 937:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 7 (MENINGIOMA)
+
|
 +
====CHAPTER 7 (MENINGIOMA)====
 
|
 
|
 
----
 
----
Line 885: Line 969:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
+
|
 +
====CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)====
 
|
 
|
 
----
 
----
Line 959: Line 1,044:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
Line 1,026: Line 1,122:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 9 (MELANOCYTIC TUMOURS)
+
|
 +
====CHAPTER 9 (MELANOCYTIC TUMOURS)====
 
|
 
|
 
----
 
----
Line 1,068: Line 1,165:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
+
|
 +
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)====
 
|
 
|
 
----
 
----
Line 1,099: Line 1,197:
 
|
 
|
 
|-
 
|-
−
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,163: Line 1,272:
 
|MS
 
|MS
 
|
 
|
−
|2021 template added
+
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
 
|-
 
|-
 
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
Line 1,208: Line 1,317:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
Line 1,231: Line 1,351:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 11 (GERM CELL TUMOURS)
+
|
 +
====CHAPTER 11 (GERM CELL TUMOURS)====
 
|
 
|
 
----
 
----
Line 1,262: Line 1,383:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 12 (TUMOURS OF THE SELLAR REGION
+
|
 +
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION====
 
|
 
|
 
----
 
----
Line 1,337: Line 1,459:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 13 (METASTASES TO THE CNS)
+
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|
 +
====CHAPTER 13 (METASTASES TO THE CNS)====
 
|
 
|
 
----
 
----
Line 1,379: Line 1,513:
 
|
 
|
 
|-
 
|-
−
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
+
|
 +
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)====
 
|
 
|
 
----
 
----
Line 1,401: Line 1,536:
 
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|Disease
 
|Disease
−
|Ngoni Faya (trainee) + Madina Sukhanova
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
|N/A
−
|-
+
|-
−
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
+
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
−
|Disease
+
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[CNS5:Schwannomatosis|Schwannomatosis]]
 
|[[CNS5:Schwannomatosis|Schwannomatosis]]
Line 1,434: Line 1,569:
 
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
 
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
Line 1,456: Line 1,591:
 
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 
|Disease
 
|Disease
−
|Jennie Thurston
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|7/2/2023
+
|N/A
−
|
+
|N/A
−
|PENDING
+
|N/A
−
|
+
|N/A
−
|LS
+
|N/A
−
|
+
|N/A
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
|N/A
 
|-
 
|-
 
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 
|Disease
 
|Disease
−
|Jennifer Laffin
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|8/22/2023
+
|N/A
−
|
+
|N/A
−
|PENDING
+
|N/A
−
|
+
|N/A
−
|LS/MS
+
|N/A
−
|
+
|N/A
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
|N/A
 
|-
 
|-
 
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
 
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
Line 1,533: Line 1,679:
 
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 
|Disease
 
|Disease
−
|Jennie Thurston
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|7/2/2023
+
|N/A
−
|
+
|N/A
−
|PENDING
+
|N/A
−
|
+
|N/A
−
|LS
+
|N/A
−
|
+
|N/A
−
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
|N/A
 
|-
 
|-
 
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
Line 1,574: Line 1,720:
 
|
 
|
 
|
 
|
 +
|-
 +
!'''Disease'''
 +
!'''Page Type'''
 +
!'''<span style="color:#0070C0">Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 
|-
 
|-
 
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
Line 1,588: Line 1,745:
 
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
 
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]

Latest revision as of 08:53, 11 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
Astrocytoma, IDH-mutant Disease Meenakshi Mehrotra 6/25/2023 PENDING Laveniya Satgunaseelan (LS) 2021 template added
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease Riley Lochner (trainee), Shashi Shetty (mentor) 6/7/2022 COMPLETE LS 2021 template added
Glioblastoma, IDH-wildtype Disease Meenakshi Mehrotra PENDING LS Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
Diffuse astrocytoma, MYB- or MYBL1-altered Disease Scott Smith 6/27/2023 COMPLETE LS 2021 template added (page created 6/27/23)
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease Scott Smith 5/3/2024 PENDING LS
Diffuse midline glioma, H3 K27-altered Disease Laveniya Satgunaseelan (Linda Cooley - previous version) PENDING LS 2021 template added
Diffuse hemispheric glioma, H3 G34-mutant Disease Xiaolin (Lynn) Hu 2/21/2022 COMPLETE LS 2021 template added
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease Madina Sukhanova 10/28/2022 COMPLETE LS 2021 template added
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease Jeremy Pulvers 9/13/2022
 PENDING LS 2021 template added
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease LS 2021 template added
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease Leila Moayed-Aloei 6/30/2022 COMPLETE LS 2021 template added
Gangliocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease Laveniya Satgunaseelan 9/11/2024 Pending Testing 9/2024 somatic template
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myxopapillary ependymoma Disease
Subependymoma Disease

CHAPTER 3 (CHOROID PLEXUS TUMOURS)
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease

CHAPTER 4 (EMBRYONAL TUMOURS)
Medulloblastoma, WNT-activated Disease Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City 9/20/21 COMPLETE Holli Drendel (interim)/Laveniya Satgunaseelan (LS) 9/22/2022 2021 template added
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease

CHAPTER 5 (PINEAL TUMOURS)
Pineocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease

CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease

CHAPTER 7 (MENINGIOMA)
Meningioma Disease

CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease

CHAPTER 9 (MELANOCYTIC TUMOURS)
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease

CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
Primary diffuse large B-cell lymphoma of the CNS Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease Jennie Thurston 7/2/2023 PENDING MS 2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)" and "ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)"?
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease

CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours of the CNS Disease

CHAPTER 12 (TUMOURS OF THE SELLAR REGION
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 13 (METASTASES TO THE CNS)
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease

CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cowden syndrome Disease See DIG5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Constitutional mismatch repair deficiency syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial adenomatous polyposis 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
ELP1-medulloblastoma syndrome Disease
Retrieved from "https://ccga.io/index.php?title=CNS5:Volunteer_Assignments_and_Opportunities&oldid=15428"